These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 6677659)

  • 21. Ocular effects and safety of antimalarial agents.
    Easterbrook M
    Am J Med; 1988 Oct; 85(4A):23-9. PubMed ID: 3177429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The blood-retinal barrier in chloroquine retinopathy.
    Raines MF; Bhargava SK; Rosen ES
    Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1726-31. PubMed ID: 2759787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chloroquine-induced ocular toxicity.
    Petrohelos MA
    Ann Ophthalmol; 1974 Jun; 6(6):615-8. PubMed ID: 4836611
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography.
    So SC; Hedges TR; Schuman JS; Quireza ML
    Ophthalmic Surg Lasers Imaging; 2003; 34(3):251-8. PubMed ID: 12757106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.
    Missner S; Kellner U
    Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):319-25. PubMed ID: 22215255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Macular complications of synthetic antimalarials. Apropos of a case].
    Ducousso F; Ballion JC; Kovalski JL; Labrouze JM; Bazin S; Bourguignon G; Saliou G
    J Fr Ophtalmol; 1995; 18(8-9):553-8. PubMed ID: 7560802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term course of chloroquine retinopathy after cessation of medication.
    Brinkley JR; Dubois EL; Ryan SJ
    Am J Ophthalmol; 1979 Jul; 88(1):1-11. PubMed ID: 463998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Idiopathic macular preretinal membrane in the elderly].
    Zhang HR
    Zhonghua Yan Ke Za Zhi; 1990 Sep; 26(5):275-8. PubMed ID: 2086137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Maculopathy in Patients Using Hydroxychloroquine.
    Uğurlu A; Aslanova M; Cebeci Z; Kır Mercül N
    Turk J Ophthalmol; 2019 Jun; 49(3):149-153. PubMed ID: 31245977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early detection of macular changes with multifocal ERG in patients on antimalarial drug therapy.
    Nebbioso M; Grenga R; Karavitis P
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):249-58. PubMed ID: 19348599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Macular syndrome].
    Stanca HT
    Oftalmologia; 2008; 52(1):22-30. PubMed ID: 18714486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.
    Lyons JS; Severns ML
    Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis and differential diagnosis of acute zonal occult outer retinopathy].
    Song ZM; Sheng YJ; Chen QS; Xue AQ; Lin B; Li YZ; Shen LJ
    Zhonghua Yan Ke Za Zhi; 2006 Aug; 42(8):717-23. PubMed ID: 17081444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The multifocal pattern electroretinogram in chloroquine retinopathy.
    Neubauer AS; Stiefelmeyer S; Berninger T; Arden GB; Rudolph G
    Ophthalmic Res; 2004; 36(2):106-13. PubMed ID: 15017107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antimalarial's retinopaty remains a current threat].
    Chiffoleau A; Guillet A; Zanlonghi X; Jolliet P
    Presse Med; 2009 Apr; 38(4):662-3. PubMed ID: 19135848
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical characteristics of hydroxychloroquine retinopathy.
    Payne JF; Hubbard GB; Aaberg TM; Yan J
    Br J Ophthalmol; 2011 Feb; 95(2):245-50. PubMed ID: 20693556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic polypoidal choroidal vasculopathy of the macula.
    Moorthy RS; Lyon AT; Rabb MF; Spaide RF; Yannuzzi LA; Jampol LM
    Ophthalmology; 1998 Aug; 105(8):1380-5. PubMed ID: 9709746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is corneal deposition of antimalarial any indication of retinal toxicity?
    Easterbrook M
    Can J Ophthalmol; 1990 Aug; 25(5):249-51. PubMed ID: 2207871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Electroretinography and synthetic antimalarial agents].
    Hudelo J
    Bull Mem Soc Fr Ophtalmol; 1982; 94():182-4. PubMed ID: 7184542
    [No Abstract]   [Full Text] [Related]  

  • 40. [Acute macular neuroretinopathy--case report].
    Pojda-Wilczek D; Herba E
    Klin Oczna; 2005; 107(1-3):127-9. PubMed ID: 16052823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.